Teva Pharma Industries (TEVA) Superinvestor holders
22 of the superinvestors we track hold Teva Pharma Industries (TEVA) in their latest 13F filings, $1.8B in total.
Summary
The largest holder is WCM Investment Management, with $1.4B, 2.5% of the portfolio.
In their latest quarter: 1 opened a new position, 8 added, 11 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| WCM Investment Management | Added | 41,315,232 | $1.4B | 2.5% | Q2 2026 |
| Larry Robbins Glenview Capital Management |
Trimmed | 5,081,091 | $172M | 3.4% | Q2 2026 |
| David Einhorn Greenlight Capital |
Trimmed | 2,886,059 | $98M | 2.5% | Q2 2026 |
| Ray Dalio Bridgewater Associates |
Added | 1,326,678 | $45M | 0.2% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
Trimmed | 1,059,778 | $36M | 0.1% | Q2 2026 |
| Stanley Druckenmiller Duquesne Family Office |
Trimmed | 624,999 | $21M | 0.5% | Q2 2026 |
| Arrowstreet Capital | Added | 525,435 | $18M | 0.0% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Trimmed | 490,000 | $17M | 0.1% | Q2 2026 |
| Jennison Associates | Trimmed | 359,114 | $12M | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Trimmed | 231,287 | $8M | 0.0% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Added | 180,647 | $6M | 0.0% | Q2 2026 |
| Alger Fred Alger Management |
Added | 174,322 | $6M | 0.0% | Q2 2026 |
| Brandon Haley Holocene Advisors |
Trimmed | 166,867 | $6M | 0.0% | Q2 2026 |
| Ron Baron Baron Capital (BAMCO) |
Added | 138,987 | $5M | 0.0% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 107,729 | $4M | 0.0% | Q2 2026 |
| Cathie Wood ARK Investment Management |
Added | 68,653 | $2M | 0.0% | Q2 2026 |
| Mario Gabelli GAMCO Investors |
Held | 66,100 | $2M | 0.0% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Held | 40,850 | $1M | 0.0% | Q2 2026 |
| Tom Steyer Farallon Capital Management LLC |
Trimmed | 40,000 | $1M | 0.0% | Q2 2026 |
| First Manhattan First Manhattan Co |
Trimmed | 30,035 | $1M | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
New position | 10,200 | $338,538 | 0.0% | Q2 2026 |
| Man Group Man Group plc |
Trimmed | 9,014 | $305,394 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 23 |
| Q1 2026 | 23 |
| Q4 2025 | 24 |
| Q3 2025 | 25 |
| Q2 2025 | 20 |
| Q1 2025 | 19 |
| Q4 2024 | 25 |
| Q3 2024 | 28 |
Questions about Teva Pharma Industries
Which superinvestors own Teva Pharma Industries?
22 of the superinvestors we track hold Teva Pharma Industries (TEVA) in their latest 13F filings, $1.8B in total. WCM Investment Management, Larry Robbins, David Einhorn, Ray Dalio, Steve Cohen, Stanley Druckenmiller.
Who is the largest superinvestor holder of TEVA?
The largest holder is WCM Investment Management, with $1.4B, 2.5% of the portfolio.
From Teva Pharma Industries's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.